$ERNA
Eterna Therapeutics Inc.

2022 Q1 Form 10-Q Financial Statement

#000114036122024669 Filed on July 01, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1
Revenue $0.00 $0.00
YoY Change -100.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $4.514M $1.673M
YoY Change 169.81% -45.68%
% of Gross Profit
Research & Development $1.782M $1.533M
YoY Change 16.24%
% of Gross Profit
Depreciation & Amortization $36.00K $25.29K
YoY Change 42.37% 9.95%
% of Gross Profit
Operating Expenses $6.296M $8.921M
YoY Change -29.42% 779.32%
Operating Profit -$6.296M -$8.921M
YoY Change -29.42% 779.32%
Interest Expense -$615.0K $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net -$3.079M -$9.601M
YoY Change -67.93% -205337.28%
Pretax Income -$9.375M -$18.52M
YoY Change -49.38% 1397.33%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$9.400M -$18.52M
YoY Change -49.25% 1717.29%
Net Earnings / Revenue
Basic Earnings Per Share -$0.17 -$0.67
Diluted Earnings Per Share -$0.17 -$0.67
COMMON SHARES
Basic Shares Outstanding 53.63K 27.80K
Diluted Shares Outstanding 53.63K 27.80K

Balance Sheet

Concept 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $23.50M $8.410M
YoY Change 179.43% 278.66%
Cash & Equivalents $23.50M $8.410M
Short-Term Investments
Other Short-Term Assets $800.0K $250.2K
YoY Change 219.69% -84.93%
Inventory
Prepaid Expenses
Receivables $24.92K
Other Receivables $28.49K
Total Short-Term Assets $25.14M $8.714M
YoY Change 188.46% 104.3%
LONG-TERM ASSETS
Property, Plant & Equipment $1.786M $568.9K
YoY Change 213.92% -87.33%
Goodwill $2.000M $2.044M
YoY Change -2.14%
Intangibles
YoY Change
Long-Term Investments $421.0K $488.5K
YoY Change -13.82%
Other Assets
YoY Change
Total Long-Term Assets $10.24M $11.98M
YoY Change -14.55% 77.57%
TOTAL ASSETS
Total Short-Term Assets $25.14M $8.714M
Total Long-Term Assets $10.24M $11.98M
Total Assets $35.38M $20.70M
YoY Change 70.91% 87.93%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.106M $1.812M
YoY Change -38.96% 130.24%
Accrued Expenses $2.384M $1.160M
YoY Change 105.46% 32.31%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $642.2K
YoY Change -68.06%
Total Short-Term Liabilities $3.684M $3.902M
YoY Change -5.59% -10.34%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $77.67K
YoY Change -100.0% 417.8%
Other Long-Term Liabilities $14.38M $22.86K
YoY Change 62800.76% -99.18%
Total Long-Term Liabilities $14.38M $22.86K
YoY Change 62800.76% -99.19%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.684M $3.902M
Total Long-Term Liabilities $14.38M $22.86K
Total Liabilities $18.07M $25.12M
YoY Change -28.08% 250.58%
SHAREHOLDERS EQUITY
Retained Earnings -$150.1M -$55.08M
YoY Change 172.5%
Common Stock $207.5K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $17.31M $14.00M
YoY Change
Total Liabilities & Shareholders Equity $35.38M $20.70M
YoY Change 70.91% 87.93%

Cashflow Statement

Concept 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income -$9.400M -$18.52M
YoY Change -49.25% 1717.29%
Depreciation, Depletion And Amortization $36.00K $25.29K
YoY Change 42.37% 9.95%
Cash From Operating Activities -$5.400M -$3.430M
YoY Change 57.44% 83.12%
INVESTING ACTIVITIES
Capital Expenditures -$46.00K $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $266.3K
YoY Change -100.0%
Cash From Investing Activities -$46.00K $266.3K
YoY Change -117.27% -6075.36%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 11.99M 9.943M
YoY Change 20.62% 3081.79%
NET CHANGE
Cash From Operating Activities -5.400M -3.430M
Cash From Investing Activities -46.00K 266.3K
Cash From Financing Activities 11.99M 9.943M
Net Change In Cash -5.400M 6.779M
YoY Change -179.65% -533.18%
FREE CASH FLOW
Cash From Operating Activities -$5.400M -$3.430M
Capital Expenditures -$46.00K $0.00
Free Cash Flow -$5.354M -$3.430M
YoY Change 56.1% 82.68%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 dei Amendment Flag
AmendmentFlag
false
CY2022Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000748592
CY2021Q1 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.5
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-6296000
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1782000
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1533000
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4514000
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1623000
CY2022Q1 us-gaap Noncash Merger Related Costs
NoncashMergerRelatedCosts
0
CY2021Q1 us-gaap Noncash Merger Related Costs
NoncashMergerRelatedCosts
5765000
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
6296000
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
8921000
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-8921000
CY2022Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0
CY2021Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-9598000
CY2022Q1 btx Warrant Liabilities Expense
WarrantLiabilitiesExpense
1322000
CY2021Q1 btx Warrant Liabilities Expense
WarrantLiabilitiesExpense
0
CY2022Q1 btx Loss On Non Controlling Investment
LossOnNonControllingInvestment
615000
CY2021Q1 btx Loss On Non Controlling Investment
LossOnNonControllingInvestment
0
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1142000
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3000
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3079000
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-9601000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9375000
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-18522000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-9375000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-18522000
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.17
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.17
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.67
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.67
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53626
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
53626
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27799
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27799
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
25503000
CY2022Q1 btx Stock Issued During Period Value Private Offering
StockIssuedDuringPeriodValuePrivateOffering
0
CY2022Q1 btx Stock Issued During Period Value Forfeiture Of Unvested Restricted Stock
StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock
0
CY2022Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1183000
CY2021Q1 btx Adjustments To Additional Paid In Capital Elimination Historical Member Equity
AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity
0
CY2021Q1 btx Stock Issued During Period Value Acquisitions1
StockIssuedDuringPeriodValueAcquisitions1
8178000
CY2021Q1 btx Stock Issued During Period Value New Issues Of Preferred Stock Retained By Stockholders
StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders
0
CY2021Q1 us-gaap Partners Capital Account Acquisitions
PartnersCapitalAccountAcquisitions
0
CY2021Q1 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
5765000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
419000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-18522000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
13999000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-9375000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
17311000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
7659000
CY2021Q1 btx Stock Issued During Period Value Rights Offering Membership Units
StockIssuedDuringPeriodValueRightsOfferingMembershipUnits
10500000
CY2022Q1 us-gaap Cash
Cash
23500000
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-150100000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-9400000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5400000
CY2022Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
11000000
CY2021Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
0
CY2022Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
12600000
CY2022Q1 btx Over Subscription Amount Received
OverSubscriptionAmountReceived
600000
CY2022Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
12000000.0
CY2022Q1 btx Over Subscription Amount Received
OverSubscriptionAmountReceived
600000
CY2021Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
0
CY2022Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
12589000
CY2022Q1 us-gaap Liabilities Fair Value Adjustment
LiabilitiesFairValueAdjustment
726000
CY2022Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
13315000
CY2022Q1 btx Operating Lease Area
OperatingLeaseArea
5200
CY2022Q1 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P62M
CY2022Q1 btx Base Rent Per Square Foot
BaseRentPerSquareFoot
6.35
CY2022Q1 btx Percentage Base Rent Increase On Each Anniversary
PercentageBaseRentIncreaseOnEachAnniversary
0.03
CY2022Q1 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
CY2022Q1 btx Lessee Commitment To Purchase Property
LesseeCommitmentToPurchaseProperty
50000
CY2022Q1 btx Unamortized Leasehold Improvements
UnamortizedLeaseholdImprovements
50000
CY2022Q1 us-gaap Deposit Assets
DepositAssets
63000
CY2022Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
186000
CY2021Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
151000
CY2022Q1 us-gaap Sublease Income
SubleaseIncome
21000
CY2021Q1 us-gaap Sublease Income
SubleaseIncome
21000
CY2022Q1 us-gaap Variable Lease Cost
VariableLeaseCost
3000
CY2021Q1 us-gaap Variable Lease Cost
VariableLeaseCost
9000
CY2022Q1 us-gaap Lease Cost
LeaseCost
168000
CY2021Q1 us-gaap Lease Cost
LeaseCost
139000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2567000
CY2022Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
102000
CY2022Q1 btx Write Off Of Operating Lease Right Of Use Asset
WriteOffOfOperatingLeaseRightOfUseAsset
1372000
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1093000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
2723000
CY2022Q1 btx Principal Payments On Operating Lease Liabilities
PrincipalPaymentsOnOperatingLeaseLiabilities
103000
CY2022Q1 btx Write Off Of Operating Lease Liability
WriteOffOfOperatingLeaseLiability
1453000
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
1167000
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1018000
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
149000
CY2022Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y9M18D
CY2022Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.1023
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
201000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
270000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
272000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
274000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
267000
CY2022Q1 btx Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
245000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1529000
CY2022Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
362000
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
1167000
CY2022Q1 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
6000000.0
CY2022Q1 us-gaap Goodwill
Goodwill
2000000.0
CY2021Q4 us-gaap Share Price
SharePrice
4.17
CY2022Q1 us-gaap Share Price
SharePrice
2.05
CY2022Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2022Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
637000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
656000
CY2022Q1 btx Accrued Research And Development Expenses
AccruedResearchAndDevelopmentExpenses
311000
CY2021Q4 btx Accrued Research And Development Expenses
AccruedResearchAndDevelopmentExpenses
222000
CY2022Q1 btx Accrued General And Administrative Expenses
AccruedGeneralAndAdministrativeExpenses
1436000
CY2021Q4 btx Accrued General And Administrative Expenses
AccruedGeneralAndAdministrativeExpenses
371000
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2384000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1249000
CY2022Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
800000
CY2022Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
800000
CY2022Q1 btx Number Of Stock Option Grant Made
NumberOfStockOptionGrantMade
2
CY2021Q1 us-gaap Stock Issued During Period Shares Reverse Stock Splits
StockIssuedDuringPeriodSharesReverseStockSplits
1514000
CY2021Q1 btx Stock Issued During Period Shares Acquisitions1
StockIssuedDuringPeriodSharesAcquisitions1
1068000
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
13407000
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
42000

Files In Submission

Name View Source Status
0001140361-22-024669-index-headers.html Edgar Link pending
0001140361-22-024669-index.html Edgar Link pending
0001140361-22-024669.txt Edgar Link pending
0001140361-22-024669-xbrl.zip Edgar Link pending
brhc10039260_10q.htm Edgar Link pending
brhc10039260_10q_htm.xml Edgar Link completed
brhc10039260_ex10-5.htm Edgar Link pending
brhc10039260_ex10-6.htm Edgar Link pending
brhc10039260_ex31-1.htm Edgar Link pending
brhc10039260_ex31-2.htm Edgar Link pending
brhc10039260_ex32-1.htm Edgar Link pending
brhc10039260_ex32-2.htm Edgar Link pending
btx-20220331.xsd Edgar Link pending
btx-20220331_cal.xml Edgar Link unprocessable
btx-20220331_def.xml Edgar Link unprocessable
btx-20220331_lab.xml Edgar Link unprocessable
btx-20220331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
image00001.jpg Edgar Link pending
image01.jpg Edgar Link pending
image02.jpg Edgar Link pending
image03.jpg Edgar Link pending
image04.jpg Edgar Link pending
image05.jpg Edgar Link pending
image06.jpg Edgar Link pending
image07.jpg Edgar Link pending
image08.jpg Edgar Link pending
image09.jpg Edgar Link pending
image10.jpg Edgar Link pending
image11.jpg Edgar Link pending
image12.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending